Circadian depression subtype linked to body clock in Australian genetics study
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedA study described in this video description reports a proposed "circadian depression" subtype in about 25% of over 10,000 Australian Genetics of Depression Study participants, linked to poorer antidepressant response; the description does not show circadian treatments are superior. [1]
The study examined clinical and genetic data from more than 10,000 Australians in the Australian Genetics of Depression Study. [1]
Researchers identified 2,604 participants, about 25% of the study population, with characteristics consistent with circadian depression. [1]
Participants with circadian depression showed poorer responses and more side effects with commonly prescribed antidepressants, including SSRIs and SNRIs. [1]
Proposed subtype in Australian depression cohort
The description reports a study in the British Journal of Psychiatry by University of Sydney researchers. It examined clinical and genetic data from more than 10,000 Australians in the Australian Genetics of Depression Study. The authors identified a potential subtype called "circadian depression," associated with disturbances in the body's 24-hour biological clock, which regulates sleep, wakefulness and other physiological processes. The description says this affected nearly one-quarter of individuals with severe, recurrent or persistent depression. [1]
Features, earlier onset and antidepressant response
Researchers identified 2,604 participants, about 25% of the study population, with characteristics consistent with circadian depression. Common features included seasonal patterns of depressive symptoms, prolonged sleep during depressive episodes, persistent tiredness upon waking and a preference for staying awake late at night. These individuals were more likely to experience depressive symptoms earlier in life and to report greater illness severity, including increased suicidal thoughts and symptoms of mania. Genetic analyses found higher susceptibility to inflammatory and cardiovascular conditions and neurodevelopmental disorders, including ADHD. Participants with circadian depression showed poorer responses and more side effects with commonly prescribed antidepressants, including SSRIs and SNRIs. [1]
Suggested circadian treatments remain unproven here
Researchers suggested that treatments targeting circadian rhythms, such as light therapy, melatonin and melatonin-targeting antidepressants, may be more suitable for some individuals with this presentation. The description states, however, that these findings do not establish that circadian-focused treatments are superior for every patient, and that treatment decisions require individual clinical assessment. Researchers believe identifying circadian-related symptoms earlier could help clinicians personalise treatment strategies. The description does not report a trial testing these treatments. [1]
Context & limits
This is a video description only; the video and transcript were not reviewed. The description reports an observational study of clinical and genetic data and does not establish causation or that circadian-focused treatments are superior. It gives no full-text details on design, follow-up or how the subtype was defined.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
more than 10,000 Australians participating
2,604 participants, representing approximately 25%
poorer responses and more side effects
About this video
Creator description · original textText language: English
Medical Dialogues · 3 min · Source published: 2026-10-21
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.